PUBLISHER: IMARC | PRODUCT CODE: 1347565
PUBLISHER: IMARC | PRODUCT CODE: 1347565
Neuromodulation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Overview:
The global neuromodulation market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.5 Billion by 2028, exhibiting a growth rate (CAGR) of 10.4% during 2023-2028.
Neuromodulation is a medical technique used for the modulation and alteration of nerve activities by delivering electrical or pharmaceutical agents directly to the targeted area. It consists of tiny electrodes that generate electrical stimulation with the help of pulse generators to supplement neurological activities in the patients. The electrodes are generally placed in the nerves, brain, or spinal cord, whereas pulse generators are implanted within the skin. Neuromodulation is widely used to treat depression, chronic pain, epilepsy, tremor, migraine, failed back syndrome, Parkinson's disease, and gastroparesis. It includes the vagal nerve, deep brain, transcranial magnetic, and electrical stimulation. It assists in monitoring nerve activity, alleviating symptoms, and normalizing activity levels in the brain.
Neuromodulation Market Trends:
The rising geriatric population and the increasing prevalence of Alzheimer's and Parkinson's diseases across the globe are key factors driving the market growth. Neuromodulation is widely used to treat overactive bladder, low movement, rigidity, tremor, walking problems, neurodegenerative, and neurological disorders. Moreover, technological innovations, such as the introduction of lithium-ion (Li-ion) batteries that provide high energy density, rechargeability, and enhanced cycling temperature, are providing a considerable boost to the market growth. Additionally, the widespread utilization of spinal cord stimulation (SCS) in various medical problems, such as complex regional pain syndrome, neuropathy, nerve damage, failed-back surgery syndrome, and arachnoiditis, is positively impacting the market growth. Apart from this, the increasing usage of deep brain stimulation (DBS) that delivers low bipolar or monopolar electric impulses and is used in the treatment of depression and obsessive-compulsive disorders (OCD) is creating a positive outlook for the market. Other factors, such as extensive research and development (R&D) activities and significant growth in the healthcare industry, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global neuromodulation market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on technology, biomaterial and application.
Breakup by Technology:
Internal Neuromodulation
Spinal Cord Stimulation (SCS)
Deep Brain Stimulation (DBS)
Vagus Nerve Stimulation (VNS)
Sacral Nerve Stimulation (SNS)
Gastric Electrical Stimulation (GES)
External Neuromodulation
Transcutaneous Electrical Nerve Stimulation (TENS)
Transcranial Magnetic Stimulation (TMS)
Others
Breakup by Biomaterial:
Metallic Biomaterials
Polymeric Biomaterials
Ceramic Biomaterials
Breakup by Application:
Parkinson's Disease
Epilepsy
Depression
Dystonia
Pain Management
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bioventus Inc., Boston Scientific Corporation, Helius Medical Technologies, Integer Holdings Corporation, LivaNova PLC, Medtronic plc, MicroTransponder Inc., Neuronetics, NeuroPace Inc., NeuroSigma Inc., Nevro Corp.
Key Questions Answered in This Report:
- How has the global neuromodulation market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global neuromodulation market?
- What are the key regional markets?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the biomaterial?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global neuromodulation market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Neuromodulation Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Technology
- 6.1 Internal Neuromodulation
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Spinal Cord Stimulation (SCS)
- 6.1.2.2 Deep Brain Stimulation (DBS)
- 6.1.2.3 Vagus Nerve Stimulation (VNS)
- 6.1.2.4 Sacral Nerve Stimulation (SNS)
- 6.1.2.5 Gastric Electrical Stimulation (GES)
- 6.1.3 Market Forecast
- 6.2 External Neuromodulation
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Transcutaneous Electrical Nerve Stimulation (TENS)
- 6.2.2.2 Transcranial Magnetic Stimulation (TMS)
- 6.2.2.3 Others
- 6.2.3 Market Forecast
7 Market Breakup by Biomaterial
- 7.1 Metallic Biomaterials
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Polymeric Biomaterials
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Ceramic Biomaterials
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Application
- 8.1 Parkinson's Disease
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Epilepsy
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Depression
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Dystonia
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Pain Management
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Bioventus Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Boston Scientific Corporation
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Helius Medical Technologies
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.5 Integer Holdings Corporation
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.6 LivaNova PLC
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.7 Medtronic plc
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 MicroTransponder Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Neuronetics
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.10 NeuroPace Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.11 NeuroSigma Inc.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.12 Nevro Corp.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.1 Abbott Laboratories
List of Figures
- Figure 1: Global: Neuromodulation Market: Major Drivers and Challenges
- Figure 2: Global: Neuromodulation Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Neuromodulation Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Neuromodulation Market: Breakup by Technology (in %), 2022
- Figure 5: Global: Neuromodulation Market: Breakup by Biomaterial (in %), 2022
- Figure 6: Global: Neuromodulation Market: Breakup by Application (in %), 2022
- Figure 7: Global: Neuromodulation Market: Breakup by Region (in %), 2022
- Figure 8: Global: Neuromodulation (Internal Neuromodulation) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 9: Global: Neuromodulation (Internal Neuromodulation) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 10: Global: Neuromodulation (External Neuromodulation) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: Neuromodulation (External Neuromodulation) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: Neuromodulation (Metallic Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: Neuromodulation (Metallic Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: Neuromodulation (Polymeric Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: Neuromodulation (Polymeric Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: Neuromodulation (Ceramic Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: Neuromodulation (Ceramic Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: Neuromodulation (Parkinson's Disease) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: Neuromodulation (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: Neuromodulation (Epilepsy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: Neuromodulation (Epilepsy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: Neuromodulation (Depression) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: Neuromodulation (Depression) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: Neuromodulation (Dystonia) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: Neuromodulation (Dystonia) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Global: Neuromodulation (Pain Management) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Global: Neuromodulation (Pain Management) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: Global: Neuromodulation (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: Global: Neuromodulation (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: North America: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: North America: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: United States: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: United States: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: Canada: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: Canada: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: Asia-Pacific: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: Asia-Pacific: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: China: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: China: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: Japan: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: Japan: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: India: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: India: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: South Korea: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: South Korea: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: Australia: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: Australia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: Indonesia: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: Indonesia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Others: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: Europe: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: Europe: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: Germany: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: Germany: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: France: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: France: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: United Kingdom: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: United Kingdom: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: Italy: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: Italy: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: Spain: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: Spain: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Russia: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Russia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: Others: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Latin America: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: Latin America: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Brazil: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Brazil: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 72: Mexico: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 73: Mexico: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 74: Others: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 75: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 76: Middle East and Africa: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 77: Middle East and Africa: Neuromodulation Market: Breakup by Country (in %), 2022
- Figure 78: Middle East and Africa: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 79: Global: Neuromodulation Industry: SWOT Analysis
- Figure 80: Global: Neuromodulation Industry: Value Chain Analysis
- Figure 81: Global: Neuromodulation Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Neuromodulation Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Neuromodulation Market Forecast: Breakup by Technology (in Million US$), 2023-2028
- Table 3: Global: Neuromodulation Market Forecast: Breakup by Biomaterial (in Million US$), 2023-2028
- Table 4: Global: Neuromodulation Market Forecast: Breakup by Application (in Million US$), 2023-2028
- Table 5: Global: Neuromodulation Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 6: Global: Neuromodulation Market: Competitive Structure
- Table 7: Global: Neuromodulation Market: Key Players
